Healthcare costs before and after stroke in patients with non-valvular atrial fibrillation who initiated treatment with rivaroxaban or warfarin

Dejan Milentijevic, Jennifer H. Lin, Yen Wen Chen, Emily Kogan, Shubham Shrivastava, Erik Sjoeland, Mark Alberts

Research output: Contribution to journalArticlepeer-review

2 Scopus citations

Fingerprint

Dive into the research topics of 'Healthcare costs before and after stroke in patients with non-valvular atrial fibrillation who initiated treatment with rivaroxaban or warfarin'. Together they form a unique fingerprint.

Medicine & Life Sciences

Social Sciences